Sign inJoin waitlistJoin the waitlist

TS

Tamara Sussman

Hematology & Oncology · Cleveland Clinic

Credentials: · · ·

History

Cleveland Clinic
2019–2021
Hematology and Medical Oncology
Cleveland Clinic Foundation
2015–2018
Cleveland Clinic
2015–2018
University of Maryland School of Medicine
2011–2015

Research

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study
JAMA Oncology · 2021 · 141 citations
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
Journal for ImmunoTherapy of Cancer · 2021 · First of 6 authors · 100 citations
Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy
Review · Journal of Oncology Practice · 2019 · First of 4 authors · 48 citations

Pauline Funchain
7 papers
Alok Khorana
6 papers
Ketih McCrae
4 papers
Patrick Ott
4 papers
Stephen Hodi
4 papers
BG
Brian Gastman
3 papers
EB
Elizabeth Buchbinder
3 papers
IS
Iris Sheng
3 papers · 2 as a fellow
Megan Insco
3 papers
Moshe Ornstein
3 papers
Rebecca Knackstedt
3 papers · 3 as a resident
Shilpa Gupta
3 papers

Clinical trials

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
Principal investigator · Withdrawn · Phase 2
Dana-Farber Cancer Institute
2022–2027
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Site PI · Recruiting · Phase 4
Coherus Oncology, Inc.
2024–2027
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Site PI · Recruiting · Phase 1
Bicara Therapeutics
2020–2027